Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IPA Immunoprecise Antibodies Ltd

Trading 12-23 14:49:15 EST

0.3901

-0.0099

-2.47%

High0.4499	Low0.3800	Vol590.38K
Open0.4499	D1 Closing0.4000	Amplitude17.47%
Mkt Cap11.25M	Tradable Cap9.89M	Total Shares28.83M
T/O236.13K	T/O Rate2.33%	Tradable Shares25.35M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"IPA","market":"US","secType":"STK","nameCN":"Immunoprecise Antibodies Ltd","latestPrice":0.3901,"timestamp":1734983342241,"preClose":0.4,"halted":0,"volume":590384,"delay":0,"floatShares":25346600,"shares":28832300,"eps":-0.74364,"marketStatus":"Trading","change":-0.0099,"latestTime":"12-23 14:49:15 EST","open":0.4499,"high":0.4499,"low":0.38,"amount":236127.54635408,"amplitude":0.17475,"askPrice":0.4,"askSize":4100,"bidPrice":0.3901,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.74364,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1734987600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4,"preHourTrading":{"tag":"盘前","latestPrice":0.42,"preClose":0.4,"latestTime":"09:26 EST","volume":7087,"amount":2951.64804642,"timestamp":1734963969947},"postHourTrading":{"tag":"盘后","latestPrice":0.4098,"preClose":0.4001,"latestTime":"16:55 EST","volume":317,"amount":129.7106,"timestamp":1734731732317},"volumeRatio":2.556371,"impliedVol":1.0458,"impliedVolPercentile":0.4861},"requestUrl":"/m/hq/s/IPA","defaultTab":"news","newsList":[{"id":"2493763210","title":"ImmunoPrecise Antibodies Shows Market Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2493763210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493763210?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:07","pubTimestamp":1734962841,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies (IPA), an AI-driven biotherapeutic research company, has shown stro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immunoprecise-antibodies-shows-market-confidence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immunoprecise-antibodies-shows-market-confidence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2493682507","title":"ImmunoPrecise Antibodies exhibits market confidence with insider transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2493682507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493682507?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:45","pubTimestamp":1734961524,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) announces significant insider activity, with key members of its executive team and subsidiary co-founders demonstrat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunoprecise-antibodies-exhibits-market-confidence-with-insider-transactions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunoprecise-antibodies-exhibits-market-confidence-with-insider-transactions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2493976330","title":"ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2493976330","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493976330?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:30","pubTimestamp":1734960600,"startTime":"0","endTime":"0","summary":"VICTORIA, British Columbia, December 23, 2024----IPA   , an AI-driven biotherapeutic research and technology company, is pleased to announce significant insider activity, with key members of its executive team and subsidiary co-founders demonstrating confidence in the Company’s strategic direction and long-term potential through substantial share purchases.Over the past week, CEO Dr. Jennifer Bath and BioStrand co-founders Dirk Van Hyfte and Ingrid Brands collectively acquired a total of 763,120 shares of IPA on the open market for an aggregate amount of USD $306,000.A Strong Signal of ConfidenceThis insider activity highlights the leadership team’s belief in IPA’s growth trajectory and transformational initiatives. Dr. Bath commented, \"Our collective investments reflect our deep confidence in IPA’s vision and our commitment to driving long-term value for our shareholders. As we advance groundbreaking initiatives in AI-driven discovery and therapeutic development, we remain focused on ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/yG6.LJqPXBwethHhSfUzVA--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0f01176db7c834ae7b851b9ad9722b99","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/yG6.LJqPXBwethHhSfUzVA--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0f01176db7c834ae7b851b9ad9722b99"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunoprecise-antibodies-ipa-demonstrates-strong-133000142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PHH","WRD","IPA","BK4121"],"gpt_icon":0},{"id":"2492173150","title":"ImmunoPrecise Antibodies to Showcase at Microcap Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492173150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492173150?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:42","pubTimestamp":1734615777,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies Ltd. is set to present at The Microcap Conference 2025, offering a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immunoprecise-antibodies-to-showcase-at-microcap-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immunoprecise-antibodies-to-showcase-at-microcap-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2492757061","title":"IPA to Present at The Microcap Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2492757061","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492757061?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:00","pubTimestamp":1734613200,"startTime":"0","endTime":"0","summary":"VICTORIA, British Columbia, December 19, 2024----IPA   , an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, in Atlantic City, NJ.IPA’s management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy, and investment opportunities.The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial int","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/lXT749vHk7snjL_ngQEgRg--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c36dbf9a8852a7c62af5ca1d31180750","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/lXT749vHk7snjL_ngQEgRg--~B/aD0zMzk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c36dbf9a8852a7c62af5ca1d31180750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ipa-present-microcap-conference-2025-130000583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PHH","IPA","WRD","BK4121"],"gpt_icon":0},{"id":"2492194824","title":"Marcus & Millichap’s Institutional Property Advisors Brokers $203 Million Sale and Arranges $127.8 Million Financing for Silicon Valley Multifamily Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2492194824","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492194824?lang=en_us&edition=fundamental","pubTime":"2024-12-19 11:16","pubTimestamp":1734578160,"startTime":"0","endTime":"0","summary":"SANTA CLARA, Calif., December 19, 2024----Institutional Property Advisors , a division of Marcus & Millichap , announced today the sale and financing of Summerwood Apartments, a 468-unit multifamily property located at 444 Saratoga Avenue in Santa Clara, California. The property sold for $203,150,000. IPA executive managing directors Philip Saglimbeni, Stanford Jones, Salvatore Saglimbeni, and senior director Alexander Tartaglia represented the seller, DWS, and procured the buyer, Interstate Equities Corporation.The Los Angeles-based IPA Capital Markets team of Brian Eisendrath, Cameron Chalfant, Jake Vitta, and Jesse Zarouk secured $127,819,000 in agency financing on behalf of Interstate Equities Corporation , a local real estate investment and management firm that primarily operates throughout California and Seattle, Washington.Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wKUZaOMdSEIKhbd3OBODkA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9bc56d8c1e5b73701687161cc5f3b329","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wKUZaOMdSEIKhbd3OBODkA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9bc56d8c1e5b73701687161cc5f3b329"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/marcus-millichap-institutional-property-advisors-031600577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z6F94.USD","GRO","BK4079","BK4121","IPA","IE0034390439.USD","MMI","IEC"],"gpt_icon":0},{"id":"2491079373","title":"QIAGEN Stock Gains Following the Latest Launch of IPA Interpret","url":"https://stock-news.laohu8.com/highlight/detail?id=2491079373","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491079373?lang=en_us&edition=fundamental","pubTime":"2024-12-13 21:04","pubTimestamp":1734095040,"startTime":"0","endTime":"0","summary":"QIAGEN N.V. QGEN recently launched Ingenuity Pathway Analysis  Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Leveraging AI technology, IPA Interpret helps researchers understand which genes are involved in a disease, a biological process or a response to a drug or environmental condition.IPA Interpret is an integrated component of QIAGEN IPA. The latest launch aims to expand the QIAGEN Digital Insight  portfolio.Earlier this month, QIAGEN reached a milestone with more than 1000 EZ2 Connect automated sample preparation instrument placements. The updated EZ2 Connect has quickly become a market-leading instrument for sample preparation and data management, contributing to more than 5,500 EZ series instruments placed globally. The latest development highlights customers’ trust in QIAGEN’s automa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qiagen-stock-gains-following-latest-130400439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1169589451.USD","LU2177674079.SGD","LU2125909247.SGD","IPA","QGEN","BK4121","HAE","LU0106261612.USD","LU0205193047.USD","LU0205194284.USD","IE00BLDYK493.USD","LU2125909593.SGD","BK4198","BK4548","BK4567","LU0012050646.USD","LU2433249047.HKD","LU2008162690.USD","PEN","BK4588","LU1923622614.USD","BK4585","BK4504","IE00B64QTZ34.USD","LU1169590202.USD","RMD","BK4082"],"gpt_icon":0},{"id":"2491498354","title":"QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2491498354","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491498354?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:05","pubTimestamp":1734037500,"startTime":"0","endTime":"0","summary":"Ingenuity Pathway Analysis Interpret extends analysis capabilities of human-curated knowledge base with AI technology. Ingenuity Pathway Analysis Interpret unlocks the full potential of biological data by streamlining interpretation process and delivering actionable insights for experiments. REDWOOD CITY, Calif. & VENLO, the Netherlands, December 12, 2024----QIAGEN  today announced the launch of Ingenuity Pathway Analysis  Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.Leveraging AI technology, IPA Interpret helps distill complex differential expression analyses into actionable insights, helping researchers understand which genes are involved in a disease, a biological process or a response to a drug or environmental condition.QIAGEN is continuously integrating AI technology in its QDI portfolio. In early 2024, QIAGEN released an AI-driven biomedical knowledgebase to drive data-driven drug discovery and in late 2023, QIAGEN re","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XypSrawTpLwFAX.iiFudQA--~B/aD0yMDQ7dz0yNDI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3b843691f01716229f6ea738cdfa81ea","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XypSrawTpLwFAX.iiFudQA--~B/aD0yMDQ7dz0yNDI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3b843691f01716229f6ea738cdfa81ea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qiagen-launches-ai-extension-ingenuity-210500942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2433249047.HKD","GRO","QGEN","LU1923622614.USD","LU2125909247.SGD","BK4121","IPA","LU2125909593.SGD"],"gpt_icon":0},{"id":"2490866339","title":"ImmunoPrecise Antibodies price target lowered to $7 from $9 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2490866339","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490866339?lang=en_us&edition=fundamental","pubTime":"2024-12-11 23:10","pubTimestamp":1733929816,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on ImmunoPrecise Antibodies (IPA) to $7 from $9 and keeps a Buy rating on the shares following the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunoprecise-antibodies-price-target-lowered-to-7-from-9-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunoprecise-antibodies-price-target-lowered-to-7-from-9-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2490659748","title":"Immunoprecise Antibodies Ltd. : H.c. Wainwright Cuts Target Price to $7 From $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2490659748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490659748?lang=en_us&edition=fundamental","pubTime":"2024-12-11 23:05","pubTimestamp":1733929552,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nAZN2T0CL6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2490830144","title":"ImmunoPrecise Antibodies Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2490830144","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490830144?lang=en_us&edition=fundamental","pubTime":"2024-12-11 18:17","pubTimestamp":1733912255,"startTime":"0","endTime":"0","summary":"NasdaqGM:IPA Earnings and Revenue Growth December 11th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 4.9%. Earnings per share  exceeded analyst estimates by 8.3%.Looking ahead, revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Life Sciences industry in the US.The company's shares are up 11% from a week ago.Be aware that  ImmunoPrecise Antibodies is showing  4 warning signs in our investment analysis and 1 of those is a bit unpleasant...","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunoprecise-antibodies-second-quarter-2025-101735881.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPA"],"gpt_icon":0},{"id":"2490019528","title":"Immunoprecise Antibodies Ltd reports results for the quarter ended October 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2490019528","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490019528?lang=en_us&edition=fundamental","pubTime":"2024-12-10 22:32","pubTimestamp":1733841129,"startTime":"0","endTime":"0","summary":"Immunoprecise Antibodies Ltd reports results for the quarter ended October 31 - Earnings SummaryImmunoprecise Antibodies Ltd IPA.OQ reported a quarterly adjusted loss of 9 cents per share for the quar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL8N3NB1A2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2490015329","title":"ImmunoPrecise Antibodies Q2 2025 GAAP EPS C$(0.09) Beats C$(0.10) Estimate, Sales C$6.13M Miss C$6.44M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2490015329","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490015329?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:51","pubTimestamp":1733838713,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 10 percent increase over losses of $(0.10) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/12/42412881/immunoprecise-antibodies-q2-2025-gaap-eps-c-0-09-beats-c-0-10-estimate-sales-c-6-13m-miss-c-6-44m-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"ImmunoPrecise Antibodies Q2 2025 GAAP EPS C$(0.09) Beats C$(0.10) Estimate, Sales C$6.13M Miss C$6.44M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2490301336","title":"Immunoprecise Antibodies Ltd Qtrly Loss per Share $0.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2490301336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490301336?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:30","pubTimestamp":1733837402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA9XJF1D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2490013395","title":"Immunoprecise Antibodies (Ipa) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2490013395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490013395?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:30","pubTimestamp":1733837402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA9XJF1D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2490013399","title":"Immunoprecise Antibodies Q2 Revenue CAD 6.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2490013399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490013399?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:30","pubTimestamp":1733837401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nPLX465824:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2490001333","title":"Immunoprecise Antibodies Q2 Net Income CAD -2.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2490001333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490001333?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:30","pubTimestamp":1733837401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nPLX465824:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2490013322","title":"Press Release: ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2490013322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490013322?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:30","pubTimestamp":1733837400,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies  Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025. Delivers $6.1 Million Q2 Revenue and Announces Strategic Plan to Reshape Biotech and AI-Driven Drug Discovery. IMMUNOPRECISE ANTIBODIES LTD.  , an AI-driven biotherapeutic research and technology company, today reported financial results for the second quarter  of its 2025 fiscal year , which ended October 31, 2024. All numbers are expressed in Canadian dollars, unless otherwise noted.\"This quarter marks a pivotal chapter for IPA as we unveil our cutting-edge in silico drug discovery tools, designed to revolutionize the landscape of novel therapeutic development. These advanced platforms offer unprecedented insights and precision, aimed at significantly reducing the time and cost associated with traditional drug discovery methods. By harnessing the power of data-driven analytics, we're ushering in a new era of efficiency and innovation in the pharmaceutical industry. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","TM","IPA","WRD","BK4555","BK4121","BK4588","BK4585","R","BK4022","PHH","03160","BK4099"],"gpt_icon":0},{"id":"2489298696","title":"Meet the 25-year-old behind Chimbridge, the viral Singlish dictionary with new terms like ‘lao hong biscuit’","url":"https://stock-news.laohu8.com/highlight/detail?id=2489298696","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489298696?lang=en_us&edition=fundamental","pubTime":"2024-12-07 06:59","pubTimestamp":1733525961,"startTime":"0","endTime":"0","summary":"What drove Daniel Goh to spend over 500 hours on a not-for-profit project? CNA Lifestyle finds out.","market":"us","thumbnail":"https://onecms-res.cloudinary.com/image/upload/s--aib1j1CJ--/c_crop,h_1125,w_1500,x_0,y_1/c_fill,g_auto,h_622,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2024/12/02/hero-daniel-goh-singlish-app.jpg?itok=mwO6Eko8","type":0,"news_type":0,"thumbnails":["https://onecms-res.cloudinary.com/image/upload/s--aib1j1CJ--/c_crop,h_1125,w_1500,x_0,y_1/c_fill,g_auto,h_622,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2024/12/02/hero-daniel-goh-singlish-app.jpg?itok=mwO6Eko8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/living/chimbridge-singlish-dictionary-daniel-goh-4781831","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["BK4077","IPA","BK4547","BK4121"],"gpt_icon":1},{"id":"2489280039","title":"Immunoprecise Antibodies Ltd  expected to post a loss of 9 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2489280039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489280039?lang=en_us&edition=fundamental","pubTime":"2024-12-06 21:34","pubTimestamp":1733492059,"startTime":"0","endTime":"0","summary":"Immunoprecise Antibodies Ltd  expected to post a loss of9cents a share - Earnings Preview Immunoprecise Antibodies Ltd IPA.OQ IPA.O is expected to show a rise in quarterly revenue when it reports  res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nL5N3N70VX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunoprecise.com","stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":0.0368},{"period":"3month","weight":-0.4028},{"period":"6month","weight":-0.6039},{"period":"1year","weight":-0.6898},{"period":"ytd","weight":-0.766}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.04828},{"month":2,"riseRate":0.25,"avgChangeRate":-0.118539},{"month":3,"riseRate":0.25,"avgChangeRate":-0.179314},{"month":4,"riseRate":0.25,"avgChangeRate":-0.038624},{"month":5,"riseRate":0.5,"avgChangeRate":-0.017976},{"month":6,"riseRate":0,"avgChangeRate":-0.179973},{"month":7,"riseRate":0.5,"avgChangeRate":-0.04032},{"month":8,"riseRate":0.5,"avgChangeRate":0.022134},{"month":9,"riseRate":0,"avgChangeRate":-0.148494},{"month":10,"riseRate":0.75,"avgChangeRate":0.07679},{"month":11,"riseRate":0,"avgChangeRate":-0.153626},{"month":12,"riseRate":0.75,"avgChangeRate":0.022487}],"exchange":"NASDAQ","name":"Immunoprecise Antibodies Ltd","nameEN":"Immunoprecise Antibodies Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Immunoprecise Antibodies Ltd(IPA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Immunoprecise Antibodies Ltd,IPA,Immunoprecise Antibodies Ltd股票,Immunoprecise Antibodies Ltd股票老虎,Immunoprecise Antibodies Ltd股票老虎国际,Immunoprecise Antibodies Ltd行情,Immunoprecise Antibodies Ltd股票行情,Immunoprecise Antibodies Ltd股价,Immunoprecise Antibodies Ltd股市,Immunoprecise Antibodies Ltd股票价格,Immunoprecise Antibodies Ltd股票交易,Immunoprecise Antibodies Ltd股票购买,Immunoprecise Antibodies Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Immunoprecise Antibodies Ltd(IPA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}